A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Oncogenes and signal transduction

Cantley, L. C., Auger, K. R., Carpenter, C. F., Duckworth, B. C., Graziani, A., Kapeller, R., & Soltoff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,697

Growth Factors and Cancer

Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,017

Growth factor signaling by receptor tyrosine kinases

Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,418

RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS

Carpenter, G. F. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004313 · Cited by 1,282

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

Morrison, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90420-3 · Cited by 815

Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

Sandgren, E. P., Luetteke, N., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752

TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas

Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., & Merlino, G. T. (1990) · Cell · doi:10.1016/0092-8674(90)90076-q · Cited by 709

DIOGENES SYNDROME

Clark, A. N. G., Mankikar, G. D., & Gray, I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91280-5 · Cited by 697

EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS

Neal, D. E., Bennett, M., Hall, R. R., Marsh, C., Abel, P., Sainsbury, J. R. C., & Harris, A. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91386-8 · Cited by 604

Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies

Masui, H., Kawamoto, T., Sato, J., Wolf, B., SATO, G. H., & Mendelsohn, J. M. (1984) · The Journal of Urology · doi:10.1016/s0022-5347(17)50005-1 · Cited by 446

Two isomeric pairs of dihydrobenzopyrazoloquinazolines: centrosymmetric dimers, chains and sheets built from C—H...N and C—H...π(arene) hydrogen bonds and π–π stacking interactions

Portilla, J., Jairo Quiroga, P., Cobo, J., Nogueras, M., Low, J. N., & Glidewell, C. (2005) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s0108270105013260 · Cited by 2

Receptor Tyrosine Kinases as Targets for Cancer Therapy Development

Gschwind, A., Fischer, O. M., & Ullrich, A. (2006) · Springer eBooks · doi:10.1007/3-540-34447-0_11 · Cited by 2

Skin Cancer Prevention

Lluria-Prevatt, M., & Alberts, D. S. (2005) · Springer eBooks · doi:10.1007/3-540-26337-3_9 · Cited by 2

The Changing Face of Innovation in Drug Discovery

Zhang, L., & Decicco, C. P. (2014) · Wiley eBooks · doi:10.1002/9781118778166.ch4 · Cited by 2

Solid-phase synthesis of 2,4-diaminoquinazolines

Wu, Z., Kim, J., Söll, R., & Dhanoa, D. S. (2000) · Biotechnology and Bioengineering · doi:10.1002/1097-0290(200021)71:2 · Cited by 2

Emerging Molecular Therapies: Small-Molecule Drugs

Workman, P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-222-8:421 · Cited by 2

Protein Kinase Inhibitors

Adams, J. L., Veal, J. M., & Shewchuk, L. M. (2008) · Protein Science Encyclopedia · doi:10.1002/9783527610754.pl04 · Cited by 2

Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells

Mehta, R. K., Tan, M., Hassan, M. K., Zhao, T., Markovitz, D. M., Lawrence, T. S., & Nyati, M. K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150711 · Cited by 1

Boron-containing anticancer agents: a target-centric review of structure–activity relationships and clinical pipeline

Lee, H. E., Kim, M. G., & Jeon, B. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01582-w · Cited by 1

Synthesis and Docking of Triazole, Pyrazole, and Schiff Base Linked Quinazolinones for Anticancer and Antimicrobial Applications

Junaid, M., Gautham, S. K., Bhoomandla, S., & Nune, S. V. K. (2026) · Letters in Organic Chemistry · doi:10.2174/0115701786430284251214170953 · Cited by 1

Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance

Chen, Y., Liu, Q.-P., Yang, S.-J., Ding, J., Lu, X.-Y., & Xie, H. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01855-0 · Cited by 1

A theoretical study on basicity behaviour of some 4-aminoquinazoline derivatives

Tay, F., & Arslan, T. (2011) · DergiPark (Istanbul University) · doi:10.20290/btdb.07240 · Cited by 1

Kinase Inhibitors for Cancer

Mortlock, A. A., & Barker, A. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00209-1 · Cited by 1

Synthesis, characterization and density functional theory investigations of the N,N-diacylaniline derivatives

Al-Sehemi, A. G., Al-Amri, R. S. A. A., & Irfan, A. (2013) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2013.07.011 · Cited by 1

Cytokines and cancer

Cooper, M. A., & Caligiuri, M. A. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50057-0 · Cited by 1

In Silico Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors

Fernandes, G. S., Pereira, M. B. D. M., Marinho, A. C. B., Machado, B., Moreira, A. C., Freitas, M. P., Lang, K. L., & Antunes, J. E. (2015) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2015.54007 · Cited by 1

Design, synthesis and evaluation of novel pyrido fused piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines

Timaniya, J. B., Parikh, P. H., Patel, M. J., & Patel, K. P. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.101225 · Cited by 1

Recent Application of Polystyrene-supported Triphenylphosphine in Solid-Phase Organic Synthesis

Rokhum, S. L., & Bez, G. (2018) · Current Organic Chemistry · doi:10.2174/1385272822666181026115752 · Cited by 1

Synthesis of Heterocycle-Appended 4-Aminoquinazolines with Antiproliferative Properties and Potential to Inhibit Tyrosine Kinases

Mphahlele, M. J., Maluleka, M. M., & Mmonwa, M. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-20283-5_18 · Cited by 1

One-pot Three-component Synthesis of Novel Quinazoline-4-carboxylic Acid and Derivatives

Gök, D. (2020) · Hacettepe Journal of Biology and Chemistry · doi:10.15671/hjbc.736847 · Cited by 1

Case Study on Receptor Tyrosine Kinases EGFR, VEGFR, and PDGFR

Lima, L. M., Barbosa, M. L. D. C., do Amaral, D. N., & Barreiro, E. J. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_95 · Cited by 1

Syntheses and molecular structures of some di(amidino)monosilanes

Bös, M., Herbig, M., Böhme, U., & Kroke, E. (2021) · Main Group Metal Chemistry · doi:10.1515/mgmc-2021-0024 · Cited by 1

2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

(1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.6.501-a · Cited by 1

Tyrosinkinaseinhibitoren

Alves, F., & Hiddemann, W. (1997) · Der Internist · doi:10.1007/s001080050120 · Cited by 1

Tykerb Discovery: A Dual EGFR and ERBB2 Tyrosine Kinase Inhibitor

Lackey, K. E., & Cockerill, G. S. (2009) · doi:10.1002/9780470524961.ch2 · Cited by 1

Skin Cancer Prevention

Lluria-Prevatt, M., Dickinson, S. E., & Alberts, D. S. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_12 · Cited by 1

Solid Phase Chemistry

Bannwarth, W. (2000) · Methods and principles in medicinal chemistry · doi:10.1002/9783527614141.ch03 · Cited by 1

Impact of Receptor Downregulation on Clearance of Two Human EGFs With Different Receptor Binding Activity

Sizemore, N., Wright, D. S., Mueller, W. T., & Kuo, B. (1996) · Peptides · doi:10.1016/s0196-9781(96)00191-x · Cited by 1

Two quinazolinones: a ring conformational study

Swamy, G. Y. S. K., Sridhar, B., Ravikumar, K., & SADANANDAM, Y. S. (2008) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s0108270107068850 · Cited by 1

Insulin reduces the requirement for EGFR transactivation in bombesin-induced DNA synthesis

Santiskulvong, C., Sinnett‐Smith, J. W., & Rozengurt, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.100 · Cited by 1

Studies on the Differential Specificity of Protein Kinases and Its Applications

Loog, M. (2001) · Cited by 1

Engineering Protein Kinases with Specificity for Unnatural Nucleotides and Inhibitors

Zhang, C., & Shokat, K. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00081-4 · Cited by 1

The Breast Cancer Phenotype and Endocrine Response: Implications for New Drug Development Initiatives

Gee, J., & Nicholson, R. (2002) · CRC Press eBooks · doi:10.1201/b14039-12

Advances in Radiation Therapy

Haas-Kogan, D. A., & Frisch, B. M. (2004) · Pediatric oncology · doi:10.1007/978-3-662-09227-9_16 · Cited by 1

Emerging Molecular Therapies

Workman, P. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_17 · Cited by 1

Caracterização do efeito inibitorio de derivados aniquinazolinicos na atividade da adenosina quinase

Marin, R. M. (2007) · doi:10.47749/t/unicamp.2007.420401

EGF-Receptor Tyrosine Kinase and 12-Lipoxygenase Activity Regulate Expression of 12-Lipoxygenase in Human Tumor Cells

Hagmann, W., & Borgers, S. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1813-0_2

Targeting Oncogenic Signaling Pathways in Human Astrocytomas

Zadeh, G. M., & Guha, A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-313-2_18

Combinations of Cytotoxic Drugs, Ionizing Radiation and EGFR Inhibitors

Lammering, G. (2006) · Springer eBooks · doi:10.1007/3-540-35662-2_8

Screening of peptidomimetic tyrosine kinase inhibitors for inducing programmed cell death

Kéri, G., Őrfi, L., Hollósy, F., Vántus, T., Érchegyi, J., Idei, M., Horváth, A., Teplán, I., Gazit, A., Peták, I., et al. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46864-6_12

Discovery of small molecule insulin mimetics as potential novel antidiabetic agents

Zhang, B. B. (2002) · Pharmacochemistry library · doi:10.1016/s0165-7208(02)80023-x

Tyrphostin AG 1478 Accelerates Hydrogen Peroxide-Induced Apoptosis in A431 Cells

Tsukada, T., Ida, H., Kawakami, A., Eguchi, K., & Harris, R. C. (2003) · Institutional Repositories DataBase (IRDB)

Lapatinib, an Anticancer Kinase Inhibitor

Lackey, K. E. (2010) · doi:10.1002/9783527630035.ch19

Caracterização da transmissão do sinal da insulina e da leptina em hipotalamo de roedores durante a anorexia induzida pelo cancer

Ropelle, E. R. (2010) · doi:10.47749/t/unicamp.2010.477520

Diverse Confirmations in the Crystal Structures of 2,3-Dihydro-2,2-dimethylquinazolin-4(1H)-one Derivatives

Sheng, J., Zhang, M., Lu, L., & Wang, X. (2012) · Journal of Chemical Crystallography · doi:10.1007/s10870-012-0303-z

Crystal Structure of 2-(4-Chlorophenyl)-1-phenethyl-2,3-dihydro-4(1H)-quinazolinone

Swamy, G. Y. S. K., & Ravikumar, K. (2006) · X-ray Structure Analysis Online · doi:10.2116/analscix.22.x71

Optimization of the Development of Old and New EGFR and MAP Kinase Inhibitors for Colorectal Cancer

Martinelli, E., Napolitano, S., Ciardiello, D., Ciardiello, F., & Troiani, T. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0233-6

Targeting EGFR and VEGFR2 Tyrosine Kinases with Positron Emission Tomography - Evaluation of two Radiotracers

Samén, E. (2013) · Figshare

Patent focus: inhibitors of tumour cell growth

Kath, J. C. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.6.803

Targeting UVB Mediated Signal Transduction Pathways for the Chemoprevention of Squamous Cell Carcinoma

Bowden, G. T., & Alberts, D. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_16

Transcriptional regulation by v-ErbA, the oncogenic counterpart of thyroid hormone receptor (TR)

Braliou, G. G. (2000) · Radboud Repository (Radboud University)

The Potential of Tyrphostins for the Therapy of Breast Cancer

Levitzki, A., & Gazit, A. (2000) · Breast Disease · doi:10.3233/bd-1999-11113

International Journal for Pharmaceutical Research Scholars (IJPRS)

Sp, T., Pk, T., Ph, J., & Gv, P. (2014)

Drug Discovery Approaches Targeting the JAK/STAT Pathway

Seidel, H. M., & Rosen, J. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_45

GROWTH FACTOR AND SIGNAL TRANSDUCTION TARGETS FOR CANCER THERAPY

Leopold, W. R., Bridges, A. J., Decker, S. J., Fry, D. W., Kraker, A. J., & Sebolt, J. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50004-8

Intracellular Mechanisms Responsible for Trypsin-induced Increase in Transepithelial Resistance in Intestinal Epithelial Cells

Wadhwani, A. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26622

Regulation der Adenylatzyklasen und der extrazellulär-signalregulierten Proteinkinasen durch den δ-Opioidrezeptor in HEK293 Zellen

Schulz, R. (2005)

kinasesventricle by Src and EGFR protein tyrosine current - Antagonistic regulation of swelling-activated Cl

Ren, Z., & Baumgarten, C. M. (2016)

Molecular Targeted Therapy

Haas-Kogan, D. A., & McBride, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00073-1

Inhibition Of Vascular Endothelial Growth Factor ( Vegf) And Stem- Cell Factor ( Scf) Receptor Kinases As Therapeutic Targets For The Treatment Of Human Diseases

Lipson, K. E., Sun, L., Liang, C., & McMahon, G. (2000) · CRC Press eBooks · doi:10.1201/9780203904244.ch11

Drug discovery and cancer genetics

Crompton, M. R. (1996) · Springer eBooks · doi:10.1007/978-1-4899-3111-5_19

Future prospects for the endocrine management of breast cancer

Gee, J. M. W. (2002) · CRC Press eBooks · doi:10.1201/b14733-19

Tyr Kinase Inhibitors as Potential Anticancer Agents

Burgess, A. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50018-7

Engineering Protein Kinases with Specificity for Unnatural Nucleotides and Inhibitors

Zhang, C., & Shokat, K. M. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50459-9

Cyclization strategies to stabilize epidermal growth factor receptor dimerization arm mimics

Hanold, L. E. (2016)

Transition from classical methods to new strategies: Mechanistic evaluation of inhibitors against Mycobacterium tuberculosis shikimate kinase

Fuanta, R. (2018)

Efeitos do tratamento com DMA 6, 7-Dimetoxi-4-N-(3' - N', N'-dimetil) fenilaminoquinazolina na aterosclerose em camundongos LDLr-/-

Tornatore, T. F. (2006) · doi:10.47749/t/unicamp.2006.398736

The Microbiome Product Urolithin A Abrogates the TGF-ò-EGFR-PAI-1 Pathway in NRK-52e Renal Epithelial Cells

Mc, C., Pirro, N. T., Ac, M., Ea, T., & Pe, G. (2020) · Journal of Cell Signaling · doi:10.35248/2576-1471.20.5.204

Modulation of Kinases by Small Molecules for Therapeutic Management of Various Diseases - Part I

Bharate, S. B. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662012200504090532

Investigating the Maintenance of Desmoid Tumors beyond Beta-catenin

Al‐Jazrawe, M. (2019) · TSpace (University of Toronto)

Epidermal growth factor receptor overexpression as a target for imaging and radiotherapy of breast cancer

Reilly, R. M. (1999) · Library and Archives Canada (Government of Canada)

Enzymes as Drug Targets

Meek, T. D. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc260

Faculty Opinions recommendation of EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons.

Chédotal, A., & Blockus, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718011102.793476889

4-Anilinoquinazoline derivatives

(1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.4.475

Automatisierung in den Lebenswissenschaften – eine kritische Betrachtung

Fleischer, H., & Thurow, K. (2019) · doi:10.1002/9783527822843.ch2

Automation in Life Sciences – A Critical Review

Fleischer, H., & Thurow, K. (2017) · doi:10.1002/9783527805297.ch2

Stroke Therapy

Nantermet, P. G., Shalen, E. F., Venkatraman, S., Zhu, H., & Mark, R. J. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc250

The pathogenesis of cancer metastasis: relevance to biotherapy

Radinsky, R., Aukerman, S. L., & Fidler, I. J. (2003) · Springer eBooks · doi:10.1007/978-94-017-2757-0_2

Protein Kinases

Sowadski, J. M., & Epstein, L. F. (2001) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0000659

Kinase Inhibitors

Todd, A., Groundwater, P. W., & Gill, J. H. (2017) · doi:10.1002/9781118696194.ch2.5

Chapter 4 convergent assembly strategies on solid supports

(1998) · Tetrahedron organic chemistry/Tetrahedron organic chemistry series · doi:10.1016/s1460-1567(98)80031-7

CXCR7 promotes foetal myoblast fusion at muscle fiber tips independently of Myomaker via a ß1integrin-EGFR-dependent mechanismPreprint

Nassari, S., Blavet, C., Duprez, D., & Fournier‐Thibault, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.08.499311

HB-EGF Promotes Horizontal Basal Cell Proliferation and Olfactory Sensory Neuron Regeneration in the Zebrafish Olfactory EpitheliumPreprint

Sireci, S., Kocagöz, Y., Alkiraz, A. S., Güler, K., Dokuzluoglu, Z., Balcioglu, E., Demirler, M. C., & Fuss, S. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.26.509477

An Efficient One-Pot Three-Component Synthesis of Novel Quinazoline-4-Carboxylic Acid and Its Ester and Amide Derivatives

Gök, D. (2022) · Hacettepe Journal of Biology and Chemistry · doi:10.15671/hjbc.1004758

Exploring QSARs for inhibitory effect of a set of EGFR tyrosine kinase inhibitors by GA-MLR and molecular Docking simulations

Deeb, O., Muhtaseb, M., & Shaik, B. (2024) · British Journal of Multidisciplinary and Advanced Studies · doi:10.37745/bjmas.2022.0455

Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics

Brizuela, L., Gyuris, J., & Mansuri, M. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_8 · Cited by 2

Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents

Levitzki, A. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-218-0_25

High-throughput screening and rational drug design

Singh, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27461-9.00013-5

USO DA BIOINFORMÁTICA PARA SELECIONAR MOLÉCULAS CANDIDATAS A FÁRMACOS

Costa, J. B., Santos, T. S. D., Franconi, L., Sathler, A. D. A., Pereira, M. B. D. M., & Antunes, J. E. (2025) · LUMEN ET VIRTUS · doi:10.56238/levv16n53-039

The Biology of Liver Metastasis

Radinsky, R., & Fidler, I. J. (1998) · Springer eBooks · doi:10.1007/978-1-4471-1506-9_3

XIIth international symposium on radiopharmaceutical chemistry: Abstracts and programme

(1997) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580400501

Sulfur-and selenium-targeting warheads: reaction-based design of electrophilic warheads for selective inhibition of enzyme

Jain, N., & Iwaoka, M. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1768658

La protéine de stress p8 permet l'adaptation des cellules cancéreuses pancréatiques aux conditions microenvironnementales extrêmes : étude de ses mécanismes d'action.

Hamidi, T. (2012) · doi:10.70675/fd163b4bz64c2z4a8cz8beazc5fca4376c97

Mise au point des outils analytiques et formels utilisés dans la recherche préclinique en oncologie.

Benay, S. (2014) · doi:10.70675/2cd5b160z1c30z4f90zaebaz62cd4b30cad2

Pharmacochimie antiprotozoaire en séries quinazoline et quinoléine : synthèse, évaluation biologique et recherchedu mécanisme d'action.

Kieffer, C. (2014) · doi:10.70675/fb94760cze8ebz485ezbe41zafe585b1fe86

Base-Free C–N Cross-Electrophile Coupling

Samanta, S., Patel, L., Manna, D., Ojeda, M., & Powers, D. C. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c05089

Discovery and computational studies of novel thiazolo[4,5-D]pyrimidine derivatives as potential anticancer agents with dual EGFR/Topo IIα inhibitory activity

Alsfouk, A. A., Othman, I. M. M., Alzahrani, A. Y. A., Saleh, A., & Nossier, E. S. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147719

Benzo[a]pyrene vs. Tapinarof: unraveling ligand-specific AHR transcriptional responses in immortalized keratinocytes

Hartung, F., Reichert, D., Hacheney, I., Rossi, A., & Haarmann‐Stemmann, T. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04574-x

BindingDB Entry 50047494: Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification.

BindingDB (2017) · UC San Diego · doi:10.7270/q2tb18sh

BindingDB Entry 50022681: FDA-approved small molecule kinase inhibitors for cancer treatment (2001-2015): Medical indication, structural optimization, and binding mode Part I.

BindingDB (2026) · UC San Diego · doi:10.7270/q2r49wkm

PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.

Bos, M., Mendelsohn, J. M., Kim, Y. M., Albanell, J., Fry, D. W., & Baselga, J. M. (1997) · PubMed · Cited by 199

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

Kunkel, M. W., Hook, K. E., Howard, C. T., Przybranowski, S. A., Roberts, B. J., Elliott, W. L., & Leopold, W. R. (1995) · Investigational New Drugs · doi:10.1007/bf00873135 · Cited by 59

Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Rae, J. M., & Lippman, M. E. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010702.10130.29 · Cited by 29

Cytoskeletal and Morphological Changes Associated with the Specific Suppression of the Epidermal Growth Factor Receptor Tyrosine Kinase Activity in A431 Human Epidermoid Carcinoma

Nelson, J. M., & Fry, D. W. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3571 · Cited by 17

Biochemical and antiproliferative properties of 4-[Ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

Fry, D. W., Nelson, J. M., Slintak, V., Keller, P. R., Rewcastle, G. W., Denny, W. A., Zhou, H., & Bridges, A. J. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00242-6 · Cited by 65